Haymarket Medical Network, a part of business media company Haymarket Media, Inc., is proud to join the Ad Council’s first ever Private Marketplace (PMP) along with other partners Cadreon, The Trade Desk and Acxiom.
All articles by Steve Duffy
Based on the blood test results, dietitians will personalize a dietary supplement regimen to which the consumer can subscribe to. Consumers can also re-test periodically to ensure that they are receiving the supplements they need.
Lower-priced versions of Humalog Mix 75/25 KwikPen (insulin lispro protamine and insulin lispro injectable suspension 100 U/mL) and Humalog Junior KwikPen (insulin lispro injection 100 U/mL) will be available soon, according to manufacturer Eli Lilly.
The FDA has granted Breakthrough Device designation to the iLet Bionic Pancreas System, a wearable device designed to autonomously control blood sugar levels in patients with diabetes and other conditions.
The FDA has granted 510(k) market clearance to the OneDraw A1C Test system, which monitors HbA1c levels in individuals with diabetes for long-term glucose control.
The investigational treatment inclisiran (The Medicines Company) was associated with a sustained reduction in low density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease (ASCVD) or ASCVD-risk equivalents and elevated LDL-C despite maximum tolerated doses of LDL-C lowering therapies.
Latest News Your top articles for TuesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses